# Phase 4, Controlled Study in Adult Subjects Undergoing Primary, 1-2 Level, Open Lumbar Spinal Fusion Surgery

> **NCT03015961** · PHASE4 · TERMINATED · sponsor: **Pacira Pharmaceuticals, Inc** · enrollment: 38 (actual)

## Conditions studied

- Postoperative Pain Management

## Interventions

- **DRUG:** EXPAREL and bupivacaine HCl
- **DRUG:** Bupivacaine HCl

## Key facts

- **NCT ID:** NCT03015961
- **Lead sponsor:** Pacira Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-02-21
- **Primary completion:** 2017-10-30
- **Final completion:** 2017-10-30
- **Target enrollment:** 38 (ACTUAL)
- **Why stopped:** Slow enrollment
- **Last updated:** 2021-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03015961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03015961, "Phase 4, Controlled Study in Adult Subjects Undergoing Primary, 1-2 Level, Open Lumbar Spinal Fusion Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03015961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*